Self-reported Marijuana Use in Electronic Cigarettes Among US Youth, 2017 to 2018.
Population Clinical
Consumer Use
Dai (2020)
Prevalence and Factors Associated With Youth Vaping Cessation Intention and Quit Attempts.
Population Clinical
Cessation
ENDS
Dai (2021)
a Longitudinal Study of Exposure to Tobacco-Related Toxicants and Subsequent Respiratory Symptoms among U.S. adults with Varying E-cigarette Use Status.
Individual Clinical
Respiratory Toxicity; Biomarkers
Relative Health Effects Of User; Biomarkers Of Exposure
Dai (2020)
Association of electronic cigarette vaping and subsequent smoking relapse among former smokers.
Population Clinical
Likelihood Of Use
Former Smokers Switching From ENDS To Tobacco
Dai (2019)
Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018.
Population Clinical
Consumer Use
Youth Use & Appeal
Dai (2019)
Changes in electronic cigarette use among U.S. Adults by cigarette smoking status, socciodemographics, and subjective depression, 2019-2020.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Dai (2022)
Use of E-Cigarettes for Nicotine, Marijuana, and Just Flavoring Among U.S. Youth.
Population Clinical
Consumer Use
Youth Use & Appeal
Dai (2020)
quantification of nicotine and major solvents in retail electronic cigarette fluids and vaped aerosols
Nonclinical
Chemical
Analysis
Dai (2018)
Exposure to Toxicants associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Dai (2022)
Trends in Urinary Biomarkers of Exposure to Nicotine and Carcinogens among adult e-Cigarette Vapers vs Cigarette Smokers in the US, 2013-2019.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Dai (2022)